课题基金 / 基金详情

Product development clinical trial and commercialisation of revolutionary bedside sleep device SleepCogni.

Product development clinical trial and commercialisation of revolutionary bedside sleep device SleepCogni.
革命性床边睡眠设备 SleepCogni 的产品开发、临床试验和商业化。
批准号:
103595
负责人:
金额:
$41.29万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Trouble to fall asleep or waking up in the middle of the night is a problem 1 in 3 around the world face. A lack of sleep leads to unhappiness, reduces performance, increases the risk of accidents and poses severe hazards to health, including cardiovascular disease and cancer. Current treatments for sleep issues do not work or are too costly, and the most frequent treatment, the sleeping pill, is highly addictive and does not provide a long-term solution. We have now developed a credible and innovative solution to the global sleep problem: SleepCogni, the bedside medical device that helps you sleep; integrating the latest scientific insights into sleep. Amongst its many features it provides a technological embedding of a treatment known to improve outcomes for patients with sleep disorders: Cognitive Behavioural Therapy. We now seek to bring this product to market to help the world sleep. To validate SleepCogni’s measurements and user experience we want to first test it in a laboratory sleep setting, before moving on to a placebo-controlled trial to confirm the effectiveness of SleepCogni to improve sleep.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
  • 批准号:
    82371721
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王星云
  • 依托单位:
增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
  • 批准号:
    82371668
  • 项目类别:
    面上项目
  • 资助金额:
    52.00万元
  • 批准年份:
    2023
  • 负责人:
    乔云波
  • 依托单位:
MAP2的m6A甲基化在七氟烷引起SST神经元树突发育异常及精细运动损伤中的作用机制研究
  • 批准号:
    82371276
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    严佳
  • 依托单位:
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
  • 批准号:
    82372327
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    马展
  • 依托单位: